Enanta Pharmaceuticals, Inc. (ENTA)
13.60
-0.20
(-1.45%)
USD |
NASDAQ |
Aug 28, 16:00
13.58
-0.02
(-0.11%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap : 396.03M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 396.03M |
| August 27, 2026 | 401.86M |
| August 26, 2026 | 412.05M |
| August 25, 2026 | 410.01M |
| August 24, 2026 | 410.59M |
| August 21, 2026 | 392.25M |
| August 20, 2026 | 382.35M |
| August 19, 2026 | 393.41M |
| August 18, 2026 | 387.30M |
| August 17, 2026 | 373.61M |
| August 14, 2026 | 383.22M |
| August 13, 2026 | 391.37M |
| August 12, 2026 | 393.12M |
| August 11, 2026 | 393.70M |
| August 10, 2026 | 402.15M |
| August 07, 2026 | 400.98M |
| August 06, 2026 | 387.67M |
| August 05, 2026 | 384.19M |
| August 04, 2026 | 387.09M |
| August 03, 2026 | 376.34M |
| July 31, 2026 | 366.17M |
| July 30, 2026 | 377.79M |
| July 29, 2026 | 361.81M |
| July 28, 2026 | 366.46M |
| July 27, 2026 | 369.95M |
| Date | Value |
|---|---|
| July 24, 2026 | 371.40M |
| July 23, 2026 | 376.34M |
| July 22, 2026 | 379.54M |
| July 21, 2026 | 390.00M |
| July 20, 2026 | 382.44M |
| July 17, 2026 | 399.30M |
| July 16, 2026 | 383.31M |
| July 15, 2026 | 384.48M |
| July 14, 2026 | 380.99M |
| July 13, 2026 | 396.39M |
| July 10, 2026 | 398.14M |
| July 09, 2026 | 414.12M |
| July 08, 2026 | 421.09M |
| July 07, 2026 | 414.41M |
| July 06, 2026 | 421.68M |
| July 02, 2026 | 439.11M |
| July 01, 2026 | 429.23M |
| June 30, 2026 | 423.71M |
| June 29, 2026 | 421.68M |
| June 26, 2026 | 406.85M |
| June 25, 2026 | 390.87M |
| June 24, 2026 | 398.72M |
| June 23, 2026 | 408.60M |
| June 22, 2026 | 388.55M |
| June 18, 2026 | 367.91M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Perspective Therapeutics, Inc. | 354.81M |
| AbbVie, Inc. | 451.45B |
| Coherus Oncology, Inc. | 217.80M |
| BridgeBio Pharma, Inc. | 14.96B |
| RenovoRx, Inc. | 75.35M |
Market Cap Related Metrics
| PS Ratio | 5.640 |
| Price to Book Value | 3.918 |
| Price | 13.60 |
| Earnings Yield | -17.73% |